Cargando…
Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections
OBJECTIVES: Teicoplanin, an antibiotic, has poor clinical efficacy when using the current drug label’s recommended regimen, which is approved by the China Food and Drug Administration. This study explores the appropriate loading and maintenance doses of teicoplanin and evaluates the therapeutic targ...
Autores principales: | Zhou, Lijuan, Gao, Yanqiu, Cao, Wei, Liu, Jia, Guan, Hongya, Zhang, Hua, Shi, Yun, Lv, Wenying, Cheng, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759846/ https://www.ncbi.nlm.nih.gov/pubmed/29379306 http://dx.doi.org/10.2147/IDR.S146961 |
Ejemplares similares
-
Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections [Corrigendum]
Publicado: (2019) -
Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features
por: Seki, Masafumi, et al.
Publicado: (2012) -
Construction and Interpretation of Prediction Model of Teicoplanin Trough Concentration via Machine Learning
por: Ma, Pan, et al.
Publicado: (2022) -
Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
por: Ueda, Takashi, et al.
Publicado: (2020) -
Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)